Worcester biotech startup receives $1.7M NIH grant
28 Aug 2020
Economic Development
Biotechnology startup Enrich Therapeutics, based in Worcester and Groton, Conn., has received a $1.7-million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institute of Health, to work on developing its proprietary single cell isolation platform, the company announced on Aug. 17.
More Topics
![Site Logo](/media/userfiles/subsite_57/images/layout/header-logo.png)
![Site Logo](/media/userfiles/subsite_57/images/layout/header-logo.png)
![Site Logo](/media/userfiles/subsite_57/images/layout/header-logo.png)